Systems for intraoperative nerve imaging

• US 8,169,696 B2
• Filed: 06/23/2010
• Issued: 05/01/2012
• Est. Priority Date: 06/04/2009
• Status: Active Grant

• Current Assignee: General Electric Company
• Original Assignee: General Electric Company
• Inventors: Yazdanfar, Siavash, Tan Hehir, Cristina Abucay, Wang, Xinghua
• Primary Examiner(s): CHOI, WILLIAM C
• Application Number:
  US12/821,731
• Publication Number:
  US 20100312122A1
• Time in Patent Office: 678 Days
• Field of Search: 359/385, 359/618, 359/798, 600/476
• US Class Current: 359/385
• CPC Class Codes: A61K 49/0021 the fluorescent group being a small organic molecule

Abstract

Disclosed are systems for intraoperative nerve imaging using compact high collection power imaging devices for fluorescence and white light imaging of myelin basic protein (MBP) nerve imaging agents during open and minimally invasive surgery.

Claims

1. A system for intraoperative nerve imaging during surgery, comprising:

one or more illumination sources for producing a visible light and an excitation light, wherein the excitation light is configured to induce fluorescence in an agent that selectively binds to myelin basic protein applied to a surgical site;

an optical objective for directing the visible light and the excitation light in a direction of the surgical site and collecting visible light and fluorescent light emitted in at least two fluorescent emission channels from the surgical site;

a signal detector in operative association with the optical objective capable of detecting the visible light and fluorescent light; and

a signal processor for processing signals corresponding to the visible light and the fluorescent light emitted in at least two fluorescent emission channels from the surgical site.

2. The system of claim 1 wherein at least one of the fluorescent emission channels tuned to image is between 450-900 nm.

3. The system of claim 1 wherein at least one of the fluorescent emission channels is between 700-900 nm.

4. The system of claim 1 wherein the at least two fluorescent emission channels allows for spectral discrimination of nerve tissue and adipose tissue.

5. The system of claim 1 wherein the processor is further capable of reconstructing images of the surgical field from the signals obtained from the signal detector and wherein said images are registered and displayed on a display device in operative association with the processor.

6. The system of claim 5 wherein the processor is further capable of multi-channel image capture using synchronized laser and white light illumination and detection.

7. The system of claim 6 wherein images are displayed at a near video rate.

8. The system of claim 1, wherein the optical objective is employed in an imaging platform for use in open surgical fields.

9. The system of claim 8 wherein the optical objective comprises an epi-illumination delivery system, said epi-illumination delivery system comprising;

a dichroic filter fiber coupled to the laser light source, said filter capable of selectively transmitting light having a specific wavelength, separating emitted light into specific wavelengths, or a combination thereof; and

one or more lenses capable of focus adjustments positioned between the dichroic filter and the surgical field.

10. The system of claim 9 wherein the lenses comprises telephoto, retrofocus, afocal zoom lens, optical compensated PanCinor zoom lens, or combinations thereof.

11. The system of claim 9 wherein the illumination sources comprises a laser light source coupled to the dichroic filter and a fiber coupled white light source positioned above the surgical field.

12. The system of claim 1, wherein the optical objective is employed in an endoscope or a handheld device.

13. The system of claim 12 wherein the optical objective comprises:

a negative meniscus lens having a first surface and a second surface;

a stop adjacent to the negative meniscus lens;

a positive lens adjacent to the negative lens and having a first surface and a second surface;

a hybrid refractive-diffractive element adjacent to the positive lens and having a first surface and a second surface, wherein one of the first surface, or the second surface comprises a diffractive surface, and

wherein the objective has an effective focal length in a range from about 0.8 mm to about 1.6 mm.

14. The system of claim 13 wherein the optical objective further comprising an optical filter comprising wherein said optical filter is a laser rejection filter, emission filter, notch filter or combination thereof.

15. The system of claim 12 wherein the one or more illuminating sources comprises a white light emitting diode and a laser diode said diodes capable of being operated in an alternating fashion.

16. The system of claim 12 wherein the detector is an array detector capable of detecting white light and fluorescent light continuously.

17. The system of claim 1 wherein the agent that selectively binds to myelin basic protein comprises:

a compound of Formula I;

18. The system of claim 17 wherein:

R¹ is a lower alkyl group of from 1 to 6 carbon atoms;

the electron donating group is a primary amine, secondary amine, tertiary amine, or alkoxy; and

the electron withdrawing group is a nitrile group or an ester.

19. The system of claim 18 wherein:

R¹ is an lower alkyl group from 1 to 6 carbon atoms;

R² is an electron donating group; and

R³ is —

SO₂R⁴ wherein R⁴ is an alkyl, substituted alkyl, amine or substituted amine.

20. The system of claim 1 wherein the agent is applied to the surgical site by intravenous injection, intraperitoneal injection, subcutaneous injection, intramuscular injection, intrathecal injection, intracerebral injection, intracerebroventricular injection, intraspinal injection, or combinations thereof.